Anu Pharma Private Limited - Due diligence report

A 360° intelligence report on Anu Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and dist…

2001-03-30 Ramachandrapuram, Telangana Active Unlisted Active Non-Compliant
Share
Connect MCP
AP Anu Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Anu Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
48/100
Trust Score
Caution Indicated

Anu Pharma Private Limited is assessed as Caution Indicated with a Trust Score of 48/100. Anu Pharma Private Limited is an active private limited indian non-government company incorporated in 2001, operating in the Chemicals and Materials sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 06 Oct 2026 from the latest processed filings. Anu Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
48/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
41/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 2 open (3.07 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Karnataka Bank Limited1 48.0 cr
The Karnataka Bank Limited1 48.0 cr
Compliance Score: 41/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2019 - filings overdue.
  • Litigation present in 2 court forum(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
NARAYANA RAO PRATHIVADA 01234567 Director 01/04/2018 6 yrs Approved
CHANDRAMOHAN VARMA NAMPALLI 01234567 Director 01/04/2018 6 yrs Approved
BUTHURU SATHYA SHASTRY 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 45
Growth signals & trust indicators
Operating for 25+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
Statutory filings appear overdue.
Compliance score is weak (41/100).
2 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence44/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment30/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 3.07 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view30/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
03 May 2023
Director appointed
CHANDRAMOHAN VARMA NAMPALLI (Additional Director)
Director appointed
BUTHURU SATHYA SHASTRY (Additional Director)
Director ceased
DEVENDER REDDY CHINNAMAIL
Director ceased
RADHAKRISHNA REDDY JETTY
07 Feb 2020
Director ceased
MOHAMMAD MUMTAZ UR RAHMAN
30 Sep 2019
Last AGM held
Annual general meeting
23 Apr 2019
Director ceased
SATYANARAYANA REDDY CHINNAMAIL
31 Mar 2019
Latest balance sheet
Filed with ROC
16 Dec 2014
Director ceased
RAJENDER SINGH SEVARAM
22 Jun 2013
Securities allotted
485050 Equity Shares Without Differential Rights - 48.51 Lakh raised
10 Apr 2012
Charge created
The Karnataka Bank Limited - 7.00 Lakh
07 Mar 2011
Charge created
Karnataka Bank Limited - 3.00 cr
16 Jan 2009
Director appointed
NARAYANA RAO PRATHIVADA (Director)
28 May 2008
Director ceased
SUNITA BADDEY
Director ceased
JAYA PRAKASH BADDEY
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
3 active director(s) / partner(s); board looks stable and experienced.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Europa Developers Private Limited U70109TG2022PTC167822 Medak, Telangana
Four O Four Software Solutions Private Limited U72900TG2021PTC155489 Medak, Telangana
Javita Consultancy Private Limited U72900TG2022PTC161798 Medak, Telangana
Amigo Hatcheries Private Limited U01403TG2012PTC083384 Medak, Telangana
Wellness Of Women Private Limited U85190TG2020PTC139844 Medak, Telangana
CHINNAMILE ORGANIC INDUSTRIES LLP AAZ-4922 Medak, Telangana
Sirathal Technologies Private Limited U62099TS2024PTC188392 Medak, Telangana
Hsv Pharma Private Limited U51909TG2022PTC163847 Medak, Telangana
Accu Rapid Diagnostic Centre Private Limited U85190TG2021PTC156302 Medak, Telangana
Jass Techtrade Private Limited U51909TG2018PTC127778 Medak, Telangana
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Anu Pharma Private Limited before audits and certifications: compliance score 41/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Anu Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Anu Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 48/100, distress signals and MSME payment-delay disclosures - know whether Anu Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Anu Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Anu Pharma Private Limited an active company?

Anu Pharma Private Limited has MCA status “Active” with a compliance score of 41/100 (Caution Indicated).

Is Anu Pharma Private Limited financially healthy?

Anu Pharma Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Anu Pharma Private Limited?

Its overall Trust Score is 48/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Anu Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Anu Pharma Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Anu Pharma Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 41/100 (Caution Indicated).

Is it risky to lend to Anu Pharma Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.